ICAAC 2015 Conference Coverage
Recently-published data evaluated the safety, efficacy, and tolerability of switching from an antiretroviral therapy (ART) to once-daily abacavir/dolutegravir/lamivudine (Triumeq, ViiV Healthcare).
Physicians face an increasing prevalence of chronic bacterial prostatitis cases that are resistant to fluoroquinolones, which have been a mainstay of treatment.
Although regulatory guidelines specify that gender‐based assessment of drug efficacy, toxicity and tolerability profiles should be incorporated into clinical trials, women are routinely underrepresented in HIV clinical trials.
Bordetella parapertussis, a "cousin" of B. pertussis, can cause a similar disease with the same symptoms.
The researchers noted that T2Candida demonstrated greater accuracy in detecting invasive candidiasis, or the presence of the Candida infection.
The findings, coupled with the cost savings involved with using cefazolin, make it an appealing first line agent for most MSSA bloodstream infections.
Vaginal rings with multiple reservoirs present a promising way for preventing sexually transmitted infections (STIs) and notably HIV infection in young women with high risk of exposure.
Within less than five years from introduction, the rate of hospital admission due to rotavirus diarrhea in children younger than 2 years dropped by 78% and that of children younger than 2 years with x-ray-proven pneumonia dropped by 46%.
The study demonstrated the MALTI-TOF and ASP programs significantly reduced the time it took to identify infecting pathogens from 32 hours pre-intervention to 6.5
New therapeutics are on the horizon to address pneumococcal disease.
The aim of the study was to develop a sensor (Microbiosensor) embedded in the base of a contact lens case that changes color when a high level of bacteria is present.
Online survey notes rate of serology testing remain high in Canada, even when vaccination history is known.
The researchers measured anticapsular antibody responses against four serotypes - 6B, 14, 19F, and 23F, at baseline and one, three, six, nine months, and a year following vaccination.
Sixty percent of the healthcare professionals offered influenza vaccine to pregnant women in adherence with vaccination guidelines.
Sign Up for Free e-newsletters
Check out what's trending
Infectious Disease Advisor Articles
- Dundee Severity Classification Improves Management of Patients With Cellulitis
- Three New Ebola Vaccines Demonstrate Persistent Immune Response
- Isavuconazole Not Noninferior to Caspofungin for Invasive Candida Infections
- Pregnant Women Commonly Refuse Vaccines
- Tap Water in Neti Pot Linked to Death From Brain-Eating Amoeba
- Prenatal Malaria Exposure Modulates Innate Immune Responses at Birth
- Best Approach to Reduce Surgical Site Infections Before Colorectal Surgery
- A Single Triple-Drug Treatment for Lymphatic Filariasis
- Cyclosporiasis Cases Markedly Higher in 2018 Than Previous 2 Years
- Mail-Based HPV Testing May Increase Access